BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 24.80
+0.40 (1.64%)
Last updated: Oct 21, 2026, 5:19 PM CEST
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 145.46 million as of October 21, 2026. It is the 21,501st most valuable company in the world and the 173rd biggest in Switzerland. Its market cap has increased by 3.25% in one year.
Market Cap
145.46M
Enterprise Value
98.32M
Revenue
4.62M
Global Rank
Country Rank
#173 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 145.46M, a decrease of -30.04%. That is a compound annual growth rate of -18.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 145.46M | 1.94% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.44B |
| Idorsia | 1.14B |
| Basilea Pharmaceutica AG | 838.38M |
| Santhera Pharmaceuticals Holding AG | 224.94M |
| Newron Pharmaceuticals | 180.53M |
| Molecular Partners AG | 116.83M |
| Xlife Sciences AG | 52.25M |
| MindMaze Therapeutics Holding | 25.33M |